Which interaction types appear on the PTCE?
Knowledge Area 1.3 lists common or life-threatening interactions and contraindications across drug–drug, drug–dietary supplement, drug–laboratory, drug–nutrient, and drug–disease pairs. The task is to recognize a listed interaction or contraindication and route it to the pharmacist, not to redesign therapy.
PTCB PTCE Content Outline (effective January 2026), Knowledge Area 1.3
Same domain
- What brand, generic, and classification knowledge is on the PTCE?
- What is a therapeutic duplication on the PTCE?
- How are strengths, doses, and dosage forms tested?
- What special handling and administration instructions are in scope?
- How does the PTCE treat side effects, adverse effects, and allergies?
- Are medication indications on the PTCE?
- What stability facts are tested for insulin, suspensions, and injectables?
- What storage conditions does the PTCE expect?
- Is reconstitution on the current PTCE?